Intra Cellular Therapies reported $11.65M in Trade Creditors for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 10.77M 3.89M
ALKERMES ALKS:US 27.7M 28.02M
Aptinyx Inc APTX:US $ 1.75M 1.13M
Biocryst Pharmaceuticals BCRX:US $ 13.88M 13.93M
Biogen BIIB:US $ 398.7M 190.5M
Bristol Myers Squibb BMY:US $ 2944M 5M
Cytokinetics CYTK:US $ 19.84M 1.25M
Esperion Therapeutics ESPR:US $ 26.83M 9.27M
Gilead Sciences GILD:US $ 583M 122M
Halozyme Therapeutics HALO:US $ 1.27M 0.28M
Intra Cellular Therapies ITCI:US $ 11.65M 2.96M
JAZZ PHA JAZZ:US $ 73.34M 26.96M
Johnson & Johnson JNJ:US $ 9309M 1746M
Marinus Pharmaceuticals MRNS:US $ 4.67M 1.54M
Minerva Neurosciences NERV:US $ 1.59M 0.27M
Nektar Therapeutics NKTR:US $ 12.62M 2.87M
Novartis NVS:US $ 5083M 470M
Prothena PRTA:US 9.32M 5.62M
Redhill Biopharma RDHL:US $ 16.93M 11.32M
Supernus Pharmaceuticals SUPN:US $ 12.32M 2.99M
Vanda Pharmaceuticals VNDA:US $ 5.1M 0.77M